↓ Skip to main content

Dove Medical Press

Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation

Overview of attention for article published in Drug Design, Development and Therapy, October 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
1 patent

Readers on

mendeley
48 Mendeley
Title
Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation
Published in
Drug Design, Development and Therapy, October 2017
DOI 10.2147/dddt.s143712
Pubmed ID
Authors

Rai Muhammad Sarfraz, Mahmood Ahmad, Asif Mahmood, Muhammad Rouf Akram, Asad Abrar

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 10%
Student > Bachelor 5 10%
Student > Postgraduate 3 6%
Student > Master 3 6%
Student > Doctoral Student 2 4%
Other 8 17%
Unknown 22 46%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 11 23%
Chemistry 5 10%
Unspecified 2 4%
Chemical Engineering 1 2%
Immunology and Microbiology 1 2%
Other 3 6%
Unknown 25 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2024.
All research outputs
#8,538,940
of 25,385,509 outputs
Outputs from Drug Design, Development and Therapy
#641
of 2,268 outputs
Outputs of similar age
#127,974
of 331,227 outputs
Outputs of similar age from Drug Design, Development and Therapy
#10
of 44 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,227 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.